medullary thyroid cancer

Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Cancer drug rivals at Loxo and Blueprint go toe-to-toe once again, and one analyst scores a (possible) win on points
Endpoints
Mon, 10/8/18 - 09:58 am
Loxo Oncology
Blueprint Medicines
medullary thyroid cancer
LOXO-292
BLU-667
AstraZeneca sells rare cancer drug to Sanofi for up to $300 million
Yahoo/Reuters
Mon, 07/27/15 - 10:00 am
AstraZeneca
Sanofi
Caprelsa
medullary thyroid cancer
An Excellent Investment in the Biotech Space?
Motley Fool
Sat, 09/21/13 - 10:08 am
Cometriq
medullary thyroid cancer
Exelixis
Will the Exelixis Hype Catch Up to Its Valuation?
Motley Fool
Tue, 09/17/13 - 11:04 am
Exelixis
Cometriq
medullary thyroid cancer
Exelixis Presents Cometriq (cabozantinib) Clinical Trial Data in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Yahoo/BusinessWire
Sun, 06/2/13 - 11:41 am
Exelixis
Cometriq
thyroid cancer
medullary thyroid cancer
ARIAD presents new preclinical data on ponatinib
The Fly on the Wall
Mon, 04/8/13 - 11:38 am
Ariad Pharmaceuticals
Ponatinib
medullary thyroid cancer
non-small cell lung cancer
JPMorgan Healthcare Conference Highlights: Exelixis
Motley Fool
Mon, 01/14/13 - 12:30 pm
Exelixis
JPMHC 2013
Cometriq
medullary thyroid cancer
Exelixis' Crowning Achievement
Motley Fool
Sat, 12/1/12 - 09:26 am
Exelixis
cabozantinib
Cometriq
thyroid cancer
medullary thyroid cancer
Exelixis Wins First Approval of Cancer Drug
Minyanville
Fri, 11/30/12 - 09:37 am
medullary thyroid cancer
Exelixis
Cometriq
Exelixis Traders Brace For Upcoming FDA Decision
Seeking Alpha
Tue, 11/27/12 - 11:10 am
FDA
Exelixis
medullary thyroid cancer
cabozantinib
2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool
Mon, 11/26/12 - 10:56 am
Theravance
Vibativ
cabozantinib
Exelis
medullary thyroid cancer
pneumonia
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Mon, 11/26/12 - 10:55 am
cabozantinib
FDA
Exelixis
medullary thyroid cancer
Exelixis Stock Treads Water Ahead Of FDA Decision
Seeking Alpha
Sat, 10/27/12 - 11:30 am
cabozantinib
medullary thyroid cancer
thyroid cancer
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thu, 08/30/12 - 09:46 am
Exelixis
cabozantinib
medullary thyroid cancer
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Yahoo
Mon, 07/30/12 - 11:00 am
FDA
cabozantinib
medullary thyroid cancer
Exelixis
Exelixis 2011: Not What the Doctor Ordered
Motley Fool
Wed, 12/28/11 - 10:05 am
Exelixis
cabozantinib
medullary thyroid cancer
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Motley Fool
Fri, 11/18/11 - 11:39 am
EMA
AstraZeneca
medullary thyroid cancer
vandetanib
Biotech Blunder Turned 20% Overnight Gain
Motley Fool
Tue, 10/25/11 - 09:25 am
Exelixis
medullary thyroid cancer
cabozantinib
Exelixis: Thyroid Cancer Drug Delays Tumor Growth
TheStreet.com
Mon, 10/24/11 - 11:38 am
Exelixis
cabozantinib
medullary thyroid cancer